BNTC:Benitec Biopharma Inc Snapshot | Charting | News | Options
$7.90   0.00%  $0.00 NASDAQ 8:00a ET
May 1 '24 		Benitec Biopharma to Participate in the Citizens JMP Life Science Conference GlobeNewswire
Last  Change Exchange
Market data is delayed by at least 15 minutes.
Markets Portfolio
    Symbol Lookup
    Latest Story
    Benitec Biopharma to Participate in the Citizens JMP Life Science Conference
     GlobeNewswire
    Full Story →

    Headline News
    Benitec Biopharma Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with BB-301 in Phase 1b/2a Study
    7:30a ET April 18 '24 GlobeNewswire
    Benitec Biopharma Announces Oversubscribed Private Placement Financing of $40.0 Million
    7:00a ET April 18 '24 GlobeNewswire
    Benitec Biopharma to Host Virtual R&D Day to Discuss BB-301 Clinical Program in Oculopharyngeal Muscular Dystrophy on April 18, 2024
    8:00a ET April 9 '24 GlobeNewswire
    More News →
    Day  0.00%Week  13.8%Month  49.1%More Charting →
    May 1 '24. Markets Closed.
    Last $7.90
    Day change   0.00%$0.00
    Open $NA
    Gap at open $NA
    Previous close $7.90
    Trading volume NA
    10 Day avg vol. 419,530
    Shares out. 8.3Mil
    Market cap. $65.9Mil
    Trading activity Below Avg.
    Previous data from yesterday, May 1 '24.

    Historical Price Performance
    3 month   181% 
    6 month   105% 
    1 year   119% 
    2 year   66.81% 

    Earnings
    Previous 12m -$10.90
    Next 12m Estimate -$2.43
    P/E ratio 0.7x
    Revenue 0Mil

    Market data provided by News provided by


    This site is published in the United States for U.S. residents only. The services offered within this site are available exclusively through our U.S. Financial Advisors. Stifel Nicolaus Financial Advisors may only conduct business with residents of the state in which they are properly registered. The information on this website is not an offer to sell or a solicitation of an offer to buy, any security, nor shall any such security be offered or sold to any person in any jurisdiction in which such offer, solicitation, purchase or sale may not lawfully be made.
    Important Disclosures | Privacy Notice | HIPAA Policy | Use of Information Policy | Business Continuity | Canada Trade Matching Statement

    Stifel, Nicolaus & Co., Inc. Member NYSE, FINRA, and SIPC.
    Stifel Nicolaus Canada Inc., is a member of CIPF/FCPE and IIROC
    Copyright © 2024 All rights reserved.